MICHAEL SWINYER: Open Payments
NPI 1790724847 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 94 payments from 15 companies in 2025. Trend: 2023 $852 · 2024 $986 · 2025 $1,650
Food & beverage: $1,550Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 26 | $301 |
| Novartis Pharmaceuticals Corporation | 14 | $260 |
| ABBVIE INC. | 18 | $183 |
| Janssen Biotech, Inc. | 4 | $176 |
| LEO Pharma Inc. | 8 | $176 |
| UCB, Inc. | 6 | $140 |
| Organon LLC | 3 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $72 |
| GENZYME CORPORATION | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
Products named: Zoryve, COSENTYX, TREMFYA, ADBRY, SKYRIZI, Bimzelx, NEXPLANON, ILUMYA.
Industry payments across UT — which companies pay providers there.
